Dr. John L Green, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4385 |
Dr. Dayne K Roberts, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4385 Fax: 704-983-5217 |
Dr. Peter B Gusmer, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4385 |
Dr. Heather Dawn Pacholke, M.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4000 Fax: 704-983-8250 |
Dr. Wade Richard Wilkerson, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Department Of Radiology, Albemarle, NC 28001 Phone: 704-984-4385 |
News Archive
Minimally invasive surgical techniques have revolutionized the treatment paraesophageal hernia-but there's continued controversy over some key technical aspects of the procedure.
New research from the University of Pittsburgh School of Medicine and the UPMC Hillman Cancer Center sheds light on how tumors use the body's regulators of immunity for their own benefit.
Proton pump inhibitors, medications that suppress acid in the stomach, appear to be associated with fractures in postmenopausal women and bacterial infections in many patients, and higher doses do not appear any more beneficial for treating bleeding ulcers, according to a series of reports in the May 10 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Immune Pharmaceuticals Ltd., a privately held Israeli company, and EpiCept Corporation today announced that they have entered into a definitive merger agreement. The transaction is anticipated to close during the first quarter of 2013 and is subject to satisfaction of certain customary closing conditions, including the approval of a majority of EpiCept shareholders.
› Verified 9 days ago